關鍵數據
17.200今開
18.070最高
9.03K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.03%換手率
16.590昨收
15.920最低
156.77K成交額
虧損本益比靜
-17.78市淨率
0.00%股息率 TTM
-74.88%ROA
18.07052週最高
0.10量比
-61.84M淨利潤
30.93M總股本
-1.5635每股盈餘TTM
1.88Beta
-1746.27%ROE
3.22052週最低
12.96%振幅
84.02%毛利率
551.79M總市值
11.20回報/風險
5.99%風險率

即將為您帶來更多新聞,敬請期待。 。 。
AVITA Medical Inc評分
0.21與上次評分對比預測7.00
財務診斷7.84
技術分析5.32
公司估值9.37
機構認同度3.00
風險評估4.63
分析師評級
買入評級
13.667目標均價
-12.67%漲幅空間
AVITA Medical Inc 最新財報電話會記錄
AVITA Medical (RCEL) 2026 年第三季法說會:營收成長 53% 調升財測指引
AVITA Medical 的 2026 年第三季財報電話會議重點包括營收成長 53%、毛利率達 84%、現金消耗減少,並將 2026 年營收財測指引上調至 9,200 萬美元至 9,400 萬美元。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
AVITA Medical Inc 簡介
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
行業生物技術與醫療研究
公司代碼RCEL
員工數量260
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Vanguard Capital Management, LLC | 4.34% |
|---|
| BlackRock Institutional Trust Company, N.A. | 3.28% |
|---|
| Geode Capital Management, L.L.C. | 1.56% |
|---|
| State Street Investment Management (US) | 1.36% |
|---|
| 股東類型 | 佔比 |
|---|
| Investment Advisor | 10.66% |
|---|
| Investment Advisor/Hedge Fund | 4.72% |
|---|
| Individual Investor | 0.96% |
|---|
| Research Firm | 0.60% |
|---|
常見問題
AVITA Medical Inc(RCEL)的當前股價是多少?
AVITA Medical Inc(RCEL)的當前股價是 16.59。
AVITA Medical Inc 的股票代碼是什麼?
AVITA Medical Inc的股票代碼是RCEL。
AVITA Medical Inc股票的52週最高點是多少?
AVITA Medical Inc股票的52週最高點是18.07。
AVITA Medical Inc股票的52週最低點是多少?
AVITA Medical Inc股票的52週最低點是3.22。
AVITA Medical Inc的市值是多少?
AVITA Medical Inc的市值是513.13M。
現在AVITA Medical Inc(RCEL)的股票是買入、持有還是賣出?
根據分析師評級,AVITA Medical Inc(RCEL)的總體評級為買入,目標價格為13.67。
AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是多少
AVITA Medical Inc(RCEL)股票的每股收益(EPS TTM)是-1.56。